Questions About High-Flying Insulet Corp.
Summary by Law Street Media
1 Articles
1 Articles
All
Left
Center
Right
Questions About High-Flying Insulet Corp.
FOIAengine: Multiple Hedge Funds Seeking Inspection Reports Leading medical device manufacturer Insulet Corporation’s stock price (NASDAQ: PODD) is on a roll. But that hasn’t stopped leading financial firms from monitoring the company’s Food and Drug Administration plant inspections to learn of any bad news that might slow its growth. During April, Wall Street analysts characterized Insulet as “revolutionizing,” “a top performer,” and a “solid w…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium